News

FDA Issues Highest Risk Warning For Mushroom Recall
Mushrooms sold across two states have been recalled over fears they could be harboring listeria, a bug that "can cause ...
FDA commissioner stirs debate over hormone therapy for menopause
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
FDA names former pharmaceutical company executive to oversee US drug program
The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
FDA appoints biotech executive as top drug regulator under RFK Jr.
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...
Biotech exec George Tidmarsh picked as FDA's chief drug regulator
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
STAT14h
New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment
The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...
FDA appoints George Tidmarsh as top drug regulator
U.S. Food and Drug Administration commissioner Marty Makary has appointed former biotech executive George Tidmarsh as the ...
Sarepta Stock Falls. Why It’s Caving Into the FDA and What Comes Next.
The company agreed to voluntarily halt shipments of its experimental medicine Elevidys for Duchenne muscular dystrophy.
FDA recalls over 67,000 cases of Power Stick deodorant due to manufacturing violations
On July 10, Pennsylvania-based health and beauty manufacturer A.P. Deauville announced a recall of 67,214 cases of its Power ...